You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chinese Adult Subjects

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer Trial in Changsha (AD16 30mg?40mg, AD16 Placebo 30mg?40mg)

Completed
  • Alzheimer Disease
  • AD16 30mg、40mg
  • AD16 Placebo 30mg、40mg
  • Changsha, China
    The Central South University Xiang Ya Hospital
Mar 28, 2023

Alzheimer Trial in Changsha (high-fat diet group(AD16 20mg), fasted group(AD16 20mg))

Completed
  • Alzheimer Disease
  • high-fat diet group（AD16 20mg）
  • fasted group（AD16 20mg）
  • Changsha, China
    The Central South University Xiang Ya Hospital
Mar 14, 2023

End Stage Renal Disease on Hemodialysis Trial in Beijing, Shijiazhuang (Difelikefalin Injection)

Recruiting
  • End Stage Renal Disease on Hemodialysis
  • Difelikefalin Injection
  • Beijing, China
  • +3 more
Jun 1, 2023

Schizophrenia Trial in China (Xanomeline and Trospium Chloride Capsules, Placebo)

Recruiting
  • Schizophrenia
  • Xanomeline and Trospium Chloride Capsules
  • Placebo
  • Beijing, Beijing, China
  • +5 more
Jun 30, 2023

Healthy Subject Trial in Chengdu (GS3-007 oral liquid)

Not yet recruiting
  • Healthy Subject
  • GS3-007 oral liquid
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 16, 2023

Healthy Trial in Chengdu (JNJ-70033093)

Completed
  • Healthy
  • Chengdu, China
    West China Hospital, Si Chuan University
Jan 3, 2023

Pharmacokinetic Trial in Changchun (Lanifibranor)

Active, not recruiting
  • Pharmacokinetic
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Nov 13, 2023

Stable Plaque Psoriasis Trial (LEO 90100, Daivobet® ointment)

Not yet recruiting
  • Stable Plaque Psoriasis
  • LEO 90100
  • Daivobet® ointment
  • (no location specified)
Jun 16, 2023

Healthy Volunteers Trial (TY-9591)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
May 15, 2023

Beta-thalassemia Trial in Nanning (Luspatercept, Placebo)

Recruiting
  • Beta-thalassemia
  • Nanning, China
  • +1 more
Jan 13, 2023

COVID-19 Trial in Beijing ([14C]STI-1558)

Not yet recruiting
  • COVID-19
  • Beijing, China
    Beijing Gaobo Boren Hospital
Mar 1, 2023

Uremic Pruritus Trial in China (Difelikefalin Injection, Placebo Injection)

Recruiting
  • Uremic Pruritus
  • Difelikefalin Injection
  • Placebo Injection
  • Baotou, China
  • +34 more
Jun 1, 2023

Asthma Trial in Hefei (MG-ZG122 Humanized Monoclonal Antibody Injection, Placebo)

Not yet recruiting
  • Asthma
  • MG-ZG122 Humanized Monoclonal Antibody Injection
  • Placebo
  • Hefei, Anhui, China
    The Second Affiliated Hospital of Anhui Medical University
Dec 13, 2022

Healthy Adult Subjects Trial in Hefei (Test drug (T1): CBP-201 injection (pre-filled syringe, 150 mg/1 mL), Test drug (T2):

Not yet recruiting
  • Healthy Adult Subjects
  • Test drug (T1): CBP-201 injection (pre-filled syringe, 150 mg/1 mL)
  • +2 more
  • Hefei, Anhui, China
    The Second Hospital of Anhui Medical University
Jun 14, 2023

Phase I: Relapsed or Refractory B-cell Malignancies, Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma, Phase II

Active, not recruiting
  • Phase I: Relapsed or Refractory B-cell Malignancies
  • +2 more
  • Beijing, China
  • +22 more
Dec 8, 2022

Pain Trial (Ibuprofen arginine granules 400 mg, Ibuprofen arginine granules 400 mg (Spedifen))

Not yet recruiting
  • Pain
  • Ibuprofen arginine granules 400 mg
  • Ibuprofen arginine granules 400 mg (Spedifen)
  • (no location specified)
Feb 10, 2023

HER2-positive Recurrent / Metastatic Breast Cancer Trial (pyrotinib tablet, Montmorillonite Power, Loperamide)

Not yet recruiting
  • HER2-positive Recurrent / Metastatic Breast Cancer
  • pyrotinib tablet
  • +2 more
  • (no location specified)
Feb 16, 2022

Neurofibromatosis 1, Neurofibroma Plexiform Trial in Shanghai (Selumetinib)

Active, not recruiting
  • Neurofibromatosis 1
  • Neurofibroma Plexiform
  • Shanghai, China
  • +1 more
Jan 13, 2023

Diet, High-Fat, Pharmacokinetics Trial in Qingdao (AL8326 tablets)

Recruiting
  • Diet, High-Fat
  • Pharmacokinetics
  • AL8326 tablets
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Aug 2, 2022

Atopic Dermatitis Trial in Changsha (QLM3003, QLM3003 Placebo)

Recruiting
  • Atopic Dermatitis
  • Changsha, Hunan, China
    The Third Xiangya Hospital of Central South University
Jul 2, 2023

Upper Respiratory Tract Infection, Lower Respiratory Infection, Skin Infection Trial in Beijing (test product (T) azithromycin

Completed
  • Upper Respiratory Tract Infection
  • +4 more
  • test product (T) azithromycin capsule and reference product (R) azithromycin capsule "Sumamed®"
  • Beijing, Beijing, China
    Peking University People's Hospital
Nov 20, 2023

Hypertrophic Cardiomyopathy Trial in Shanghai (Mavacamten)

Completed
  • Hypertrophic Cardiomyopathy
  • Shanghai, Shanghai, China
    Huashan Hospital Fudan University
Jul 28, 2022

Dry Eye Disease Trial in Shanghai (Varenicline Tartrate Nasal Spray)

Recruiting
  • Dry Eye Disease
  • Varenicline Tartrate Nasal Spray
  • Shanghai, China
    Huashan Hospital
Dec 14, 2022

Healthy Subjects Trial in Jinan (Pyrotinib;Fluconazole)

Completed
  • Healthy Subjects
  • Jinan, Shandong, China
    Jinan Central Hospital
Oct 19, 2021

Myelofibrosis Trial in Changchun (TQ05105 Tablets)

Completed
  • Myelofibrosis
  • TQ05105 Tablets
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Aug 1, 2023